berdazimer · Zelsuvmi

Small molecule

Also known as SB206

Approvedregulatory verdict

Evidence outlook

Approved: Molluscum Contagiosum

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Reliable signal

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (3)
Molluscum Contagiosum
Phase 2 (1)
Molluscum Contagiosum
NCT03436615 · Novan, Inc.
2018-01-24 – 2018-11-03 · Molluscum Contagiosum
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

No upcoming readouts on record for this asset.